{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:51:30Z","timestamp":1794808290247,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of major projects","award":["31941001"],"award-info":[{"award-number":["31941001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51903074"],"award-info":[{"award-number":["51903074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Technologies R&D Program of Henan Province","award":["212102310252"],"award-info":[{"award-number":["212102310252"]}]},{"name":"the Young TopNotch Talents Foundation of Henan Agricultural University","award":["30500737"],"award-info":[{"award-number":["30500737"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of viral infectious diseases has become a serious threat to public safety, economic and social development. Vaccines have been served as the most effective platform to prevent virus transmission via the activation of host immune responses, while the low immunogenicity or safety, the high cost of production, storage, transport limit their effective clinical application. Therefore, there is a need to develop a promising strategy to improve the immunogenicity and safety of vaccines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed a splenic-targeting biomimetic nanovaccine (NV) that can boost protective humoral and cellular immunity against african swine fever virus (ASFV) infection. The universal PLGA nanoparticles (CMR-PLGA\/p54 NPs) coated with mannose and CpG (TLR9 agonist) co-modified red blood cell (RBC) membrane were prepared, which comprised a viral antigen (p54) and can be served as a versatile nanovaccine for elevating protective immunity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CMR-PLGA\/p54 NVs could be effectively uptaken by BMDC and promoted BMDC maturation in vitro. After subcutaneous immunization, antigen could be effectively delivered to the splenic dendritic cells (DCs) due to the splenic homing ability of RBC and DC targeting capacity of mannose, which promoted antigen presentation and DCs maturation, and further elicited higher levels of cytokines secretion and specific IgG titers, CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells activation and B maturation. Moreover, NVs demonstrated notable safety during the immunization period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates the high potential of CMR-PLGA NPs as vaccine delivery carriers to promote humoral and cellular immune responses, and it provides a promising strategy to develop safe and effective vaccines against viral infectious diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-022-01730-0","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T21:11:51Z","timestamp":1670101911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection"],"prefix":"10.1186","volume":"20","author":[{"given":"Jian","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanghang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daopeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"29416","DOI":"10.1021\/acsami.1c08143","volume":"13","author":"H Dong","year":"2021","unstructured":"Dong H, et al. Improved antiviral activity of classical swine fever virus-targeted siRNA by tetrahedral framework nucleic acid-enhanced delivery. ACS Appl Mater Interfaces. 2021;13:29416\u201323.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","volume":"182","author":"DM Morens","year":"2020","unstructured":"Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182:1077\u201392.","journal-title":"Cell"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tibs.2020.01.007","volume":"45","author":"Y Xian","year":"2020","unstructured":"Xian Y, Xiao C. The structure of ASFV advances the fight against the disease. Trends Biochem Sci. 2020;45:276\u20138.","journal-title":"Trends Biochem Sci"},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.aaz1439","volume":"366","author":"N Wang","year":"2019","unstructured":"Wang N, et al. Architecture of African swine fever virus and implications for viral assembly. Science. 2019;366:640\u20134.","journal-title":"Science"},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1124\/pharmrev.120.000285","volume":"74","author":"S Pecetta","year":"2022","unstructured":"Pecetta S, et al. Immunology and technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines. Pharmacol Rev. 2022;74:313\u201339.","journal-title":"Pharmacol Rev"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3390\/v13122552","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Prevention and control strategies of African swine fever and progress on pig farm repopulation in China. Viruses. 2021;13:2552\u201370.","journal-title":"Viruses"},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12951-021-01116-8","volume":"19","author":"S Han","year":"2021","unstructured":"Han S, et al. Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB\/PLGA nano-vaccine. J Nanobiotechnology. 2021;19:394\u2013416.","journal-title":"J Nanobiotechnology"},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/pharmaceutics13040455","volume":"13","author":"KC Petkar","year":"2021","unstructured":"Petkar KC, et al. An overview of nanocarrier-based adjuvants for vaccine delivery. Pharmaceutics. 2021;13:455\u201384.","journal-title":"Pharmaceutics"},{"key":"1730_CR9","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.nano.2019.102023","volume":"20","author":"Y Hu","year":"2019","unstructured":"Hu Y, et al. Alum as an adjuvant for nanoparticle based vaccines: a case study with a hybrid nanoparticle-based nicotine vaccine. Nanomedicine. 2019;20:102023\u201334.","journal-title":"Nanomedicine"},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1021\/acs.nanolett.0c03646","volume":"21","author":"Z Meng","year":"2021","unstructured":"Meng Z, et al. Ultrasound-mediated remotely controlled nanovaccine delivery for tumor vaccination and individualized cancer immunotherapy. Nano Lett. 2021;21:1228\u201337.","journal-title":"Nano Lett"},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","volume":"11","author":"P He","year":"2015","unstructured":"He P, Zou Y, Hu Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum Vacc Immunother. 2015;11:477\u201388.","journal-title":"Hum Vacc Immunother"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Le Thanh","year":"2020","unstructured":"Le Thanh T, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305\u20136.","journal-title":"Nat Rev Drug Discov"},{"key":"1730_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, et al. mRNA vaccines\u2014a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"18211","DOI":"10.1021\/acsami.9b21776","volume":"12","author":"J Sharma","year":"2020","unstructured":"Sharma J, et al. A self-adjuvanted, modular, antigenic VLP for rapid response to influenza virus variability. ACS Appl Mater Interfaces. 2020;12:18211\u201324.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","volume":"15","author":"MD Shin","year":"2020","unstructured":"Shin MD, et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol. 2020;15:646\u201355.","journal-title":"Nat Nanotechnol"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"2008960","DOI":"10.1002\/adfm.202008960","volume":"31","author":"JD Yang","year":"2021","unstructured":"Yang JD, et al. Pro-peptide-reinforced, mucus-penetrating pulmonary siRNA delivery mitigates cytokine storm in pneumonia. Adv Funct Mater. 2021;31:2008960\u201373.","journal-title":"Adv Funct Mater"},{"key":"1730_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.02.016","author":"D Yadav","year":"2022","unstructured":"Yadav D, et al. Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials. Semin Cancer Biol. 2022. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.016.","journal-title":"Semin Cancer Biol"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","volume":"115","author":"DJ Irvine","year":"2015","unstructured":"Irvine DJ, et al. Synthetic nanoparticles for vaccines and immunotherapy. Chem Rev. 2015;115:11109\u201346.","journal-title":"Chem Rev"},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"1703539","DOI":"10.1002\/smll.201703539","volume":"14","author":"L Qiu","year":"2018","unstructured":"Qiu L, et al. Endolysosomal-escape nanovaccines through adjuvant-induced tumor antigen assembly for enhanced effector CD8+ T cell activation. Small. 2018;14:1703539\u201350.","journal-title":"Small"},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1021\/acsnano.7b00978","volume":"11","author":"G Zhu","year":"2017","unstructured":"Zhu G, et al. Efficient nanovaccine delivery in cancer immunotherapy. ACS Nano. 2017;11:2387\u201392.","journal-title":"ACS Nano"},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1021\/nn500216y","volume":"8","author":"Z Xu","year":"2014","unstructured":"Xu Z, et al. Nanoparticle-delivered transforming growth factor-beta siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment. ACS Nano. 2014;8:3636\u201345.","journal-title":"ACS Nano"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2014.07.040","volume":"192","author":"LJ Cruz","year":"2014","unstructured":"Cruz LJ, et al. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. J Control Release. 2014;192:209\u201318.","journal-title":"J Control Release."},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"129192","DOI":"10.1016\/j.cej.2021.129192","volume":"416","author":"A Yang","year":"2021","unstructured":"Yang A, et al. Doxorubicin\/CpG self-assembled nanoparticles prodrug and dendritic cells co-laden hydrogel for cancer chemo-assisted immunotherapy. Chem Eng J. 2021;416:129192\u2013204.","journal-title":"Chem Eng J"},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"125854","DOI":"10.1016\/j.cej.2020.125854","volume":"399","author":"X Shi","year":"2020","unstructured":"Shi X, et al. Co-assembled and self-delivered epitope\/CpG nanocomplex vaccine augments peptide immunogenicity for cancer immunotherapy. Chem Eng J. 2020;399:125854\u201366.","journal-title":"Chem Eng J"},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1126\/sciimmunol.aat7117","volume":"5","author":"EK Grasset","year":"2020","unstructured":"Grasset EK, et al. Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells. Sci Immunol. 2020;5:7117\u201352.","journal-title":"Sci Immunol"},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"30983","DOI":"10.1021\/acsami.8b09348","volume":"10","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Nanovaccine incorporated with hydroxychloroquine enhances antigen cross-presentation and promotes antitumor immune responses. ACS Appl Mater Interfaces. 2018;10:30983\u201393.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"2104068","DOI":"10.1002\/adfm.202104068","volume":"31","author":"P Xiao","year":"2021","unstructured":"Xiao P, et al. Nanovaccine-mediated cell selective delivery of neoantigens potentiating adoptive dendritic cell transfer for personalized immunization. Adv Funct Mater. 2021;31:2104068\u201379.","journal-title":"Adv Funct Mater"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1021\/acs.nanolett.9b00030","volume":"19","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Targeted codelivery of an antigen and dual agonists by hybrid nanoparticles for enhanced cancer immunotherapy. Nano Lett. 2019;19:4237\u201349.","journal-title":"Nano Lett"},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","volume":"12","author":"R Yang","year":"2018","unstructured":"Yang R, et al. Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. ACS Nano. 2018;12:5121\u20139.","journal-title":"ACS Nano"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.03.012","volume":"206","author":"D Zhu","year":"2019","unstructured":"Zhu D, et al. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination. Biomaterials. 2019;206:25\u201340.","journal-title":"Biomaterials"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2021.121313","volume":"280","author":"Y Du","year":"2022","unstructured":"Du Y, et al. Engineering mannosylated pickering emulsions for the targeted delivery of multicomponent vaccines. Biomaterials. 2022;280:13\u201324.","journal-title":"Biomaterials"},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"130867","DOI":"10.1016\/j.cej.2021.130867","volume":"426","author":"K Liu","year":"2021","unstructured":"Liu K, et al. A novel multifunctional vaccine platform with dendritic cell-targeting and pH-responsive for cancer immunotherapy: Antigen-directed biomimetic fabrication of a cabbage-like mannatide-zinc-antigen hybrid microparticles. Chem Eng J. 2021;426:130867\u201377.","journal-title":"Chem Eng J"},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.biochem.0c00343","volume":"60","author":"X Ai","year":"2021","unstructured":"Ai X, et al. Emerging approaches to functionalizing cell membrane-coated nanoparticles. Biochemistry. 2021;60:941\u201355.","journal-title":"Biochemistry"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245\u201352.","journal-title":"Nature"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1002\/anie.201913700","volume":"59","author":"G Wu","year":"2020","unstructured":"Wu G, Zhang J, et al. Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew Chem Int Ed. 2020;59:4068\u201374.","journal-title":"Angew Chem Int Ed"},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.matt.2019.08.007","volume":"1","author":"D Wen","year":"2019","unstructured":"Wen D, et al. Adipocytes as anticancer drug delivery depot. Matter. 2019;1:1203\u201314.","journal-title":"Matter"},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.matt.2020.05.017","volume":"3","author":"Q Ma","year":"2020","unstructured":"Ma Q, et al. Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles. Matter. 2020;3:287\u2013301.","journal-title":"Matter"},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","volume":"15","author":"J Xiong","year":"2021","unstructured":"Xiong J, et al. Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer. ACS Nano. 2021;15:19756\u201370.","journal-title":"ACS Nano"},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/CJI.0000000000000096","volume":"38","author":"JD Gibbins","year":"2015","unstructured":"Gibbins JD, et al. Splenic dendritic cells involved in cross-tolerance of tumor antigens can play a stimulatory role in adoptive T-cell therapy. J Immunother. 2015;38:321\u20139.","journal-title":"J Immunother"},{"key":"1730_CR40","doi-asserted-by":"publisher","first-page":"9574","DOI":"10.1073\/pnas.1806501115","volume":"115","author":"H Li","year":"2018","unstructured":"Li H, et al. Mechanics of diseased red blood cells in human spleen and consequences for hereditary blood disorders. Proc Natl Acad Sci USA. 2018;115:9574\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1126\/sciadv.aaw6870","volume":"5","author":"X Han","year":"2019","unstructured":"Han X, et al. Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy. Sci Adv. 2019;5:6870\u20139.","journal-title":"Sci Adv"},{"key":"1730_CR42","doi-asserted-by":"publisher","first-page":"114006","DOI":"10.1016\/j.addr.2021.114006","volume":"179","author":"N Krishnan","year":"2021","unstructured":"Krishnan N, Fang RH, Zhang L. Engineering of stimuli-responsive self-assembled biomimetic nanoparticles. Adv Drug Deliv Rev. 2021;179:114006\u201316.","journal-title":"Adv Drug Deliv Rev"},{"key":"1730_CR43","doi-asserted-by":"publisher","first-page":"13809","DOI":"10.1021\/acsnano.9b04071","volume":"13","author":"Y Du","year":"2019","unstructured":"Du Y, et al. Exploiting the lymph-node-amplifying effect for potent systemic and gastrointestinal immune responses via polymer\/lipid nanoparticles. ACS Nano. 2019;13:13809\u201317.","journal-title":"ACS Nano"},{"key":"1730_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biomaterials.2017.11.021","volume":"155","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, et al. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction. Biomaterials. 2018;155:165\u201375.","journal-title":"Biomaterials"},{"key":"1730_CR45","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/ijms21051753","volume":"21","author":"YH Hwang","year":"2020","unstructured":"Hwang YH, Kim SJ, Yee ST. Physcion-matured dendritic cells induce the differentiation of Th1 cells. Int J Mol Sci. 2020;21:1753\u201366.","journal-title":"Int J Mol Sci"},{"key":"1730_CR46","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1136\/jitc-2021-003633","volume":"10","author":"J Hu","year":"2022","unstructured":"Hu J, et al. Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors. J Immunother Cancer. 2022;10:3633\u201348.","journal-title":"J Immunother Cancer"},{"key":"1730_CR47","doi-asserted-by":"publisher","first-page":"121341","DOI":"10.1016\/j.biomaterials.2021.121341","volume":"281","author":"Y Luo","year":"2022","unstructured":"Luo Y, et al. IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy. Biomaterials. 2022;281:121341\u201352.","journal-title":"Biomaterials"},{"key":"1730_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omto.2022.01.003","volume":"24","author":"J Wenthe","year":"2022","unstructured":"Wenthe J, et al. Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition. Mol Ther-Oncolytics. 2022;24:429\u201342.","journal-title":"Mol Ther-Oncolytics"},{"key":"1730_CR49","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/v13071212","volume":"13","author":"H Turlewicz-Podbielska","year":"2021","unstructured":"Turlewicz-Podbielska H, et al. African Swine fever virus as a difficult opponent in the fight for a vaccine-current data. Viruses. 2021;13:1212\u201332.","journal-title":"Viruses"},{"key":"1730_CR50","doi-asserted-by":"publisher","first-page":"715582","DOI":"10.3389\/fimmu.2021.715582","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Structure of African Swine Fever Virus and associated molecular mechanisms underlying infection and immunosuppression: a review. Front Immunol. 2021;12:715582\u201399.","journal-title":"Front Immunol"},{"key":"1730_CR51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/vaccines8030531","volume":"8","author":"K Wu","year":"2020","unstructured":"Wu K, et al. Current State of Global African Swine Fever vaccine development under the prevalence and transmission of ASF in China. Vaccines (Basel). 2020;8:531\u201358.","journal-title":"Vaccines (Basel)"},{"key":"1730_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202204692","author":"KP Chen","year":"2022","unstructured":"Chen KP, et al. mRNA vaccines against SARS-CoV-2 variants delivered by lipid nanoparticles based on novel ionizable lipids. Adv Funct Mater. 2022. https:\/\/doi.org\/10.1002\/adfm.202204692.","journal-title":"Adv Funct Mater"},{"key":"1730_CR53","doi-asserted-by":"publisher","first-page":"20211336","DOI":"10.1084\/jem.20211336","volume":"219","author":"MSJ Lee","year":"2022","unstructured":"Lee MSJ, et al. B cell-intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice. J Exp Med. 2022;219:20211336\u201361.","journal-title":"J Exp Med"},{"key":"1730_CR54","doi-asserted-by":"publisher","first-page":"109961","DOI":"10.1016\/j.celrep.2021.109961","volume":"37","author":"WT Yewdell","year":"2021","unstructured":"Yewdell WT, et al. Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection. Cell Rep. 2021;37:109961\u201380.","journal-title":"Cell Rep."}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01730-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T08:04:08Z","timestamp":1670141048000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01730-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01730-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved and reviewed by the Institutional Animal Care and Use Committee of Henan Agricultural University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approve the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"514"}}